IOBT
IO Biotech
IOBT
IOBT
Delisted
IOBT was delisted on the 6th of April, 2026.
27 hedge funds and large institutions have $18.2M invested in IO Biotech in 2024 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
75% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 4
Holders
27
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$440K | |
| 2 | +$269K | |
| 3 | +$74.6K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$59.7K |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
+$32.5K |
Top Sellers
| 1 | -$3.82M | |
| 2 | -$1.34M | |
| 3 | -$519K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$60.5K |
| 5 |
Two Sigma Investments
New York
|
-$31.5K |